Skip to content

Public FDA record

Z-2042-2009: Biomet 8.0MM cannulated reamer for the Aimer system, Biomet Sports Medicine, Ontario, CA; REF 909618.

Recall record Z-2042-2009 for Biomet, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2042-2009
Company in FDA record
Biomet, Inc.
FDA classification date
Sep 8, 2009
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

These surgical instruments are etched with incorrect measurement markings.

Source facts

Action
Consignees were notified by letter dated 8/6/09 to remove the instrument from use and to return the recalled instrument to Biomet. Implanting surgeons were notified by letter dated 8/6/09, advised of the problem and it was suggested that the patients be monitored for instability if deemed necessary by the surgeon.
Initiated
2009-08-06
Root cause
Nonconforming Material/Component
Terminated
2010-10-06
Distribution
Nationwide Distribution -- Including the state of Texas.
Recall number
Z-2042-2009
Recall status
Terminated
CDRH record ID
84221
FDA classified
2009-09-08
Recall event number
52885

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗